Everest Medicines Licenses Micot’s MT1013 for Secondary Hyperparathyroidism in $178M Deal
Everest Medicines Limited (HKG: 1952) announced a licensing agreement with Micot, a polypeptide NME drug...
Micot
Micot Raises Over RMB 100 Million in Series D Funding Led by Zheshang Venture Capital
Micot, a polypeptide new molecular entity (NME) drug developer with operations in mainland China, Hong...